Skip to content

Clinical trials

Phase 2/3 Anemia, Refractory, with Excess of Blasts trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Phase: Phase 2/3 Country / region: United States Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chimeric Therapies1
Roswell Park Cancer Institute1
Taiho Oncology, Inc.1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts4
Leukemia4
Leukemia, Myeloid, Acute4
Myelodysplastic Syndromes4
Leukemia, Myeloid, Accelerated Phase3
Leukemia, Myeloid, Chronic-Phase3
Leukemia, Myelomonocytic, Chronic3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Anemia, Refractory2
Leukemia, Biphenotypic, Acute2

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.